LysoPC(20:2)
|
Basic information |
| Metabolite name | LysoPC(20:2) |
 | N/A |
 |
C04230 |
 |
N/A |
| Synonyms | NA |
| No. of studies | 6 |
|
Basic information |
| Metabolite name | LysoPC(20:2) |
| N/A |
|
C04230 |
|
N/A |
| Synonyms | NA |
| No. of studies | 6 |
|
Relationship between LysoPC(20:2) and depression (count: 6) |
| Study | Study Type  |
Comparison groups | Tissue | Organism | Up/Down regulated |
| Study M1024 | Type1 | CUMS group vs. control group | Serum | ICR mouse | Down |
| Study M1024 | Type2 | CUMS + hydroxytyrosol group vs. CUMS group | Serum | ICR mouse | Up |
| Study M1117 | Type1 | MDD group vs. control group, Chinese cohort | Plasma | Human | Up |
| Study M1117 | Type1 | MDD group vs. control group, Russian cohort | Plasma | Human | Down |
| Study M619 | Type1 | CUMS group vs. control group | Serum | Sprague-Dawley rat | Up |
| Study M619 | Type2 | CUMS + low dose of Jiaotaiwan group vs. CUMS group | Serum | Sprague-Dawley rat | Down |
| Study M619 | Type2 | CUMS + high dose of Jiaotaiwan group vs. CUMS group | Serum | Sprague-Dawley rat | Down |
| Study M890 | Type1 | CUMS group vs. control group | Plasma | Sprague-Dawley rat | Down |
| Study M907 | Type1 | MDD group vs. control group | Plasma | Human | Down |
| Study M972 | Type1 | CRS + irradiation group vs. control group | Serum | Sprague-Dawley rat | Down |
| Study M972 | Type2 | CRS + irradiation + Paeoniae Radix Alba group vs. CRS + irradiation group | Serum | Sprague-Dawley rat | Up |